Physician profile
Anna B Holub
NPI 1356677637
$3,576.32
in general payments reported to CMS, 2019-2025
24 companies · $1,059 in 2025
The $1,059 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $462 · 2022: $853 · 2023: $606 · 2024: $596 · 2025: $1,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,261.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $522.66 | 2024-2025 | Zurzuvae |
| Novo Nordisk INC | $371.15 | 2021-2025 | Wegovy |
| Exeltis, USA INC. | $330.76 | 2021-2025 | Slynd |
| Astellas Pharma US INC | $329.99 | 2022-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $287.99 | 2021-2025 | |
| Amgen INC. | $266.49 | 2021-2025 | Evenity, Prolia |
| Millicent US INC | $215.37 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Pfizer INC. | $168.73 | 2022-2024 | |
| Evofem Biosciences, INC. | $166.11 | 2021-2024 | Phexxi |
| Abbvie INC. | $154.43 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $150.21 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $114.38 | 2025 | Gemtesa |
| Organon LLC | $91.86 | 2021-2024 | Nexplanon |
| Merck Sharp & Dohme LLC | $68.71 | 2021-2025 | Gardasil 9 |
| Exact Sciences Corporation | $67.90 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $66.81 | 2021-2023 | Twirla |
| Therapeuticsmd, INC. | $53.84 | 2021-2022 | |
| Applied Medical Resources Corporation | $38.59 | 2022 | |
| Dexcom, INC. | $22.27 | 2024 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $21.66 | 2022 | |
| Davol INC. | $21.52 | 2021 | |
| Coopersurgical, INC. | $15.72 | 2022 | |
| Currax Pharmaceuticals LLC | $15.49 | 2023 | Contrave |
| Minerva Surgical, INC | $13.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Holub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.